Search
10 Jul TARDOX Study: Targeting liver tumours with focused ultrasound for triggered drug delivery of thermosensitve liposomes is safe, feasible and enhances delivered dose
Much like a magnifying glass can focus energy from the sun to burn a hole in paper, ultrasound can be focused deep within the body to induce therapeutic effects in tumours, including ablation, hyperthermia and other bioeffects
07 Jul With Aging Comes Increasing Cost of Life-Extending Medications
MedicalResearch.com Interview with: Jonathan H. Watanabe, PharmD, PhD, BCGP Associate Professor of Clinical Pharmacy National Academy of Medicine Anniversary Fellow in Pharmacy Division of Clinical Pharmacy | Skaggs School of Pharmacy and Pharmaceutical Sciences | University of California San Diego La Jolla, CA MedicalResearch.com: What is the background for this...
05 Jul Investigational RNAi Drug Patisiran Show Promise in Hereditary Amyloidosis
For the first time: 1) anti-amyloid therapy is able to improve polyneuropathy and QOL at 18 months compared to baseline showing reversal of the disease. 2) Efficacy is observed regardless of the stages of the disease.
05 Jul TPOXXÒ (tecovirimat): Novel Antiviral Agent in the Event of a Smallpox Epidemic
Currently, there are no therapies approved for the treatment of smallpox infection. A smallpox bioterror attack could be especially damaging because the majority of today’s population is not immune to the virus, as routine vaccination ended in the 1970s
02 Jul Not All Pancreatic Cancers are the Same: Some Have Treatable Mutations
MedicalResearch.com Interview with: Michael J. Pishvaian, MD, PhD Phase I Program Director Assistant Professor Lombardi Comprehensive Cancer Center Washington, DC 20007 MedicalResearch.com: What is the background for this study? What are the main findings? Response: Pancreatic cancer is a deadly disease and will soon be the second leading cause of...
29 Jun Anti-Cancer Mechanism of Curcumin Outlined
In the present study, we asked whether Curcumin also affects tumor cell metabolism and if so, how. We show that curcumin inhibits a central enzyme of the cell metabolism, the ATP-Synthase, that stands at the end of the chain that burns sugar and produces energy
28 Jun Study Finds Serotonin Boosts Neural Plasticity By Speeding Up Rate of Learning
Our results suggest that serotonin boosts neural plasticity by influencing the rate of learning.
27 Jun Enzalutamide (Xtandi) Provides Men with NonMetastatic Castration Resistant Prostate Cancer an Effective Treatment Option
Enzalutamide significantly delayed the time to metastases development by almost 2 years compared to placebo with a 71% reduction in the risk of metastases or death
27 Jun More Evidence Ancient Retrovirus Linked to Type 1 Diabetes
The evidence that pHERV-W Env virus plays a role in the pathogenesis of type 1 diabetes is growing.
26 Jun Melanoma Compromises Quality of Life, especially in Later Stages
We surveyed 87 melanoma patients and learned that quality of life among melanoma patients was considerably lower than that of age- and gender-matched general population.15 Jun REMfresh® Study (CRA-melatonin™) Advances Use of Melatonin for Sleep Complaints
MedicalResearch.com Interview with: David C. Brodner, M.D. Founder and Principle Physician, The Center for Sinus, Allergy, and Sleep Wellness Double Board-Certified in Otolaryngology (Head and Neck Surgery) and Sleep Medicine Assistant Clinical Professor, Florida Atlantic University College of Medicine Medical Director, Good Samaritan Hospital Sleep Laboratory Senior Medical Advisor, Physician’s...14 Jun Secret Relationship of Regulatory T cells, Tregs, on Basophils
MedicalResearch.com Interview with: Jagadeesh BAYRY, DVM, PhD, HDR Scientist CRCN/Associate Professor-INSERM Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 1138 Centre de Recherche des Cordeliers PARIS , FRANCE MedicalResearch.com: What is the background for this study? What are the main findings? Response: Basophils are rare granulocytes...14 Jun African Americans Less Likely To Be Treated With Statins
Posted at 11:16h
in Author Interviews, Duke, Heart Disease, JAMA, Lipids, Race/Ethnic Diversity, Statins
MedicalResearch.com Interview with: Michael G. Nanna, MD Fellow, Division of Cardiology Duke University Medical Center Durham, NC MedicalResearch.com: What is the background for this study? Response: We know that African Americans are at higher risk for cardiovascular disease than white patients. We also know that African American individuals have been less likely...
12 Jun Long Term HIV Viral Suppression Reduces But Does Not Eliminate Elevated Cancer Risk
MedicalResearch.com Interview with: Lesley S. Park, PhD, MPH Instructor, Medicine- Primary Care and Population Health BioStanford Center for Population Health Sciences (PHS) Associate Director, Research and Data Strategy; Director, PHS Postdoctoral Fellowship Veterans Aging Cohort Study (VACS) Cancer Core Co-Director MedicalResearch.com: What is the background for this study? What are...06 Jun Urinary Biomarkers Identify Early Problems With Hip Replacements
MedicalResearch.com Interview with: Rick Sumner, PhD, FAAA The Mary Lou Bell McGrew Presidential Professor for Medical Research Chair, Department of Cell & Molecular Medicine (formerly, Anatomy and Cell Biology) Rush University Medical Center Chicago, IL 60612 MedicalResearch.com: What is the background for this study? What are the main findings?...06 Jun First in Class Antibody-Drug Conjugate Shows Promise in Metastatic Breast Cancer
MedicalResearch.com Interview with: Dr. Aditya Bardia MD, MPH Assistant Professor, Medicine Harvard Medical School Attending Physician, Medical Oncology Massachusetts General Hospital MedicalResearch.com: What is the background for this study? What are the main findings? Response: Hormone receptor-positive (HR+)/ and human epidermal growth factor receptor 2-negative (HER2-) breast cancer is the...31 May Prostate Cancer: ERLEADA (apalutamide) Delayed Metastases While Not Reducing Quality of Life
MedicalResearch.com Interview with: Dr. Fred Saad, MD FRCS Professor and Chief of Urology Director of GU Oncology Raymond Garneau Chair in Prostate Cancer University of Montreal Hospital Center (CHUM) Director, Prostate Cancer Research , Montreal Cancer Institute MedicalResearch.com: What is the background for this study? What are the main findings?...30 May Allergic Rhinitis Can Impair Adolescent Sleep and School Performance
MedicalResearch.com Interview with: Michael S. Blaiss, MD, FACAAI Executive Medical Director American College of Allergy, Asthma & Immunology Arlington Heights, IL 60005 MedicalResearch.com: Is this research important? Why or why not? Response: There has not been a comprehensive review of how allergic rhinitis impacts the adolescent population. Most studies put...30 May Apalutamide (Erleada™) Extended Metastasis-Free Survival in Resistant Prostate Cancer
MedicalResearch.com Interview with: Dr. Fred Saad, MD FRCS Full Professor and Chief of Urologic Oncology, CHUM; Medical Director of Interdisciplinary Urologic Oncology Group, CHUM; Department of Surgery/Faculty of Medicine; Institut du cancer de Montréal/CRCHUM MedicalResearch.com: What is the background for this study? What are the main findings? Response: The SPARTAN...30 May PlaqueTec Liquid Biopsies Give Alternative Data To Systemic Biomarkers
MedicalResearch.com Interview with: Dr. Nick West, MD PlaqueTec Chief Medical Officer and Consultant Interventional Cardiologist Royal Papworth Hospital NHS Foundation Trust MedicalResearch.com: What is the background for this study? Response: Recent data have identified residual inflammatory risk as a potential therapeutic target to modulate future risk of coronary and vascular...30 May TREMFYA® (guselkumab) Successfully Treats Difficult Psoriasis Areas
MedicalResearch.com Interview with: Andrew Blauvelt, M.D., M.B.A. President Oregon Medical Research Center MedicalResearch.com: What is the background for this study? What are the main findings? Response: This new paper focuses on treatment of psoriasis in classically difficult-to-treat areas of the body, which include the scalp, the palms/soles, and the fingernails....22 May Study Confirms Dupilumab Reduces Asthma Exacerbations
MedicalResearch.com Interview with: Mario Castro, M.D., M.P.H. Alan A. and Edith L. Wolff Professor of Pulmonary and Critical Care Medicine, Professor of Medicine, Pediatrics, and Radiology Washington University School of Medicine MedicalResearch.com: What is the background for this study? What are the main findings? Response: This is a confirmatory phase...22 May RNA-Editing Tool Corrects Collagen Deficit in Severe Blistering Disorder
MedicalResearch.com Interview with: Daniel de Boer Founding Chief Executive Officer ProQR MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by dystrophic epidermolysis bullosa? Response: Dystrophic epidermolysis bullosa (DEB) is caused by a mutation in the COL7A1 gene which is responsible for the formation of...22 May If Maternal Grandmother is Obese, So is Grandchild?
MedicalResearch.com Interview with: Rebecca Somerville MB BCh BAO, BMedSci, MRCPI, MPH, PhD School of Public Health, Physiotherapy and Sports Science University College Dublin Dublin, Ireland MedicalResearch.com: What is the background for this study? What are the main findings? Response: Rates of obesity in the Western world have increased dramatically over...22 May Amyloid Biomarker Predictive of Mortality in Non-STEMI Heart Attack
MedicalResearch.com Interview with: Prof. Dr. med. Konstantinos Stellos,MD, FAHA, FESC Cardiovascular Research Centre, Institute of Genetic Medicine Newcastle upon Tyne United Kingdom MedicalResearch.com: What is the background for this study? Response: Risk stratification of patients with a non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains a major challenge in clinical...21 May Widely Use Antibacterial in Hand Sanitizers and Toothpaste Can Attack Biofilms
MedicalResearch.com Interview with: Christopher M. Waters PhD Departments of Microbiology and Molecular Genetics BEACON Center for The Study of Evolution in Actio Michigan State University East Lansing, MI MedicalResearch.com: What is the background for this study? What are the main findings? Response: Our research really centers on understanding and targeting...17 May DARZALEX® (daratumumab) Approved for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible
MedicalResearch.com Interview with: Andrzej Jakubowiak, MD, PhD Professor of Medicine Director, Myeloma Program University of Chicago MedicalResearch.com: What is the background for this announcement? Would you briefly explain what is meant by multiple myeloma? Response: DARZALEX (daratumumab) in combination with VELCADE (bortezomib), melphalan and prednisone – VMP – received...11 May Sciatica: Biomarker Demonstrates Inflammation, Not Just Compression of Nerve Roots
Posted at 17:50h
in Author Interviews, Biomarkers, Brigham & Women's - Harvard, Orthopedics, Pain Research
MedicalResearch.com Interview with: Daniel Albrecht, PhD Research Fellow in Radiology, Harvard Medical School Research Fellow, Massachusetts General Hospital MedicalResearch.com: What is the background for this study? What are the main findings? Response: A great deal of preclinical work in animal models of pain has established that activation of peripheral immune...